These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10410857)

  • 21. [The most common cutaneous vasculitides. Often life-threatening].
    Schulz H
    MMW Fortschr Med; 2010 Nov; 152(46):43-5. PubMed ID: 21229725
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous drug reactions in the pediatric population.
    Noguera-Morel L; Hernández-Martín Á; Torrelo A
    Pediatr Clin North Am; 2014 Apr; 61(2):403-26. PubMed ID: 24636653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition and management of severe cutaneous drug reactions.
    Knowles SR; Shear NH
    Dermatol Clin; 2007 Apr; 25(2):245-53, viii. PubMed ID: 17430761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adverse cutaneous reactions to drugs].
    Suástegui-Rodríguez I; Campos-Jiménez KI; Domínguez-Cherit J; Méndez-Flores S
    Rev Med Inst Mex Seguro Soc; 2018; 56(1):64-70. PubMed ID: 29368897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on pediatric cutaneous drug eruptions.
    Song JE; Sidbury R
    Clin Dermatol; 2014; 32(4):516-23. PubMed ID: 25017462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug eruptions: approaching the diagnosis of drug-induced skin diseases.
    Nigen S; Knowles SR; Shear NH
    J Drugs Dermatol; 2003 Jun; 2(3):278-99. PubMed ID: 12848112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of histological presentation in erythroderma.
    Megna M; Sidikov AA; Zaslavsky DV; Chuprov IN; Timoshchuk EA; Egorova U; Wenzel J; Nasyrov RA
    Int J Dermatol; 2017 Apr; 56(4):400-404. PubMed ID: 28191631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current problems in the treatment and prevention of drug-induced toxicodermas].
    Tarasenko GN; Basalkevich GP; Patronov IV; Peredernin SF; Tarasenko IuG; Sebekina OV
    Voen Med Zh; 2000 Mar; 321(3):33-6. PubMed ID: 10815537
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse cutaneous reactions to antidepressants.
    Warnock JK; Knesevich JW
    Am J Psychiatry; 1988 Apr; 145(4):425-30. PubMed ID: 2964795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed drug eruptions: presentation, diagnosis, and management.
    Flowers H; Brodell R; Brents M; Wyatt JP
    South Med J; 2014 Nov; 107(11):724-7. PubMed ID: 25365443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sorafenib-induced eruption resembling pityriasis rubra pilaris.
    Paz C; Querfeld C; Shea CR
    J Am Acad Dermatol; 2011 Aug; 65(2):452-453. PubMed ID: 21763585
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug eruptions in children: a review of 111 cases seen in a tertiary skin referral centre.
    Khoo BP; Giam YC
    Singapore Med J; 2000 Nov; 41(11):525-9. PubMed ID: 11284609
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers.
    Summers EM; Bingham CS; Dahle KW; Sweeney C; Ying J; Sontheimer RD
    JAMA Dermatol; 2013 Jul; 149(7):814-8. PubMed ID: 23636109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous Manifestation of Drug Allergy and Hypersensitivity.
    Zalewska-Janowska A; Spiewak R; Kowalski ML
    Immunol Allergy Clin North Am; 2017 Feb; 37(1):165-181. PubMed ID: 27886905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous drug reactions: diagnosis and etiology].
    Bonnetblanc JM; Nouaille Y
    Rev Prat; 2000 Jun; 50(12):1300-4. PubMed ID: 10972069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug eruptions: recognition and treatment.
    Greenberg RD
    Compr Ther; 1986 May; 12(5):6-12. PubMed ID: 2940048
    [No Abstract]   [Full Text] [Related]  

  • 37. Residents' corner February 2013. DeRmpath & Clinic - differential diagnosis in lichenoid reactions.
    Travassos AR; Soares-de-Almeida L
    Eur J Dermatol; 2013; 23(1):129. PubMed ID: 23360906
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cutaneous side effects of targeted cancer drugs].
    Below J; Homey B; Gerber PA
    Hautarzt; 2017 Jan; 68(1):12-18. PubMed ID: 27885401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
    Bircher AJ; Flückiger R; Buchner SA
    Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bullous dermatosis at distant sites in patients treated with heparin].
    Castellanos-González M; Velasco-Rodríguez D; Mancebo Plaza AB
    Med Clin (Barc); 2016 May; 146(9):402-7. PubMed ID: 26701130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.